Peptides and combinations of peptides for use in immunotherapy against acute myeloid leukemia (aml) and other hematological neoplasms
US-2025339503-A1 · Nov 6, 2025 · US
Direct analysis of the library members per se by physical methods, e.g. spectroscopy
Direct analysis of the library members per se by physical methods, e.g. spectroscopy · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C40B20/08 |
| Official title | Direct analysis of the library members per se by physical methods, e.g. spectroscopy |
| Display label | Direct analysis of the library members per se by physical methods, e.g. spectroscopy |
| Total patents | 28 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 2 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Therapeutic drug for lipid-peroxidation-induced diseases and screening method for therapeutic drugs for lipid-peroxidation-induced diseases
US-12306164-B2 · May 20, 2025 · US
Microfluidic analysis of ligand induced cell expression
US-12083512-B2 · Sep 10, 2024 · US
System and method for isolation and qualification of nucleic acids
US-11913062-B2 · Feb 27, 2024 · US
Therapeutic drug for lipid-peroxidation-induced diseases and screening method for therapeutic drugs for lipid-peroxidation-induced diseases
US-2023324359-A1 · Oct 12, 2023 · US
Therapeutic drug for lipid-peroxidation-induced diseases and screening method for therapeutic drugs for lipid-peroxidation-induced diseases
US-2023324358-A1 · Oct 12, 2023 · US
Bacterial delivery vehicles comprising tracer nucleic acid sequences
US-2023112827-A1 · Apr 13, 2023 · US
Therapeutic drug for lipid-peroxidation-induced diseases and screening method for therapeutic drugs for lipid-peroxidation-induced diseases
US-11519893-B2 · Dec 6, 2022 · US
Bacterial delivery vehicles comprising tracer nucleic acid sequences
US-11421222-B2 · Aug 23, 2022 · US
Method for profiling protein methylation
US-10942186-B2 · Mar 9, 2021 · US
Bacterial delivery vehicles comprising tracer nucleic acid sequences
US-2021002631-A1 · Jan 7, 2021 · US
Methods for modulating ATRX-dependent gene repression
US-10858650-B2 · Dec 8, 2020 · US
Adaptive gas analyzer
US-10677713-B1 · Jun 9, 2020 · US
Therapeutic drug for lipid-peroxidation-induced diseases and screening method for therapeutic drugs for lipid-peroxidation-induced diseases
US-2020158709-A1 · May 21, 2020 · US
System and method for isolation and qualification of nucleic acids
US-2020087708-A1 · Mar 19, 2020 · US
Identification and isolation of antibodies from white blood cells
US-2019056398-A1 · Feb 21, 2019 · US
Nuclear receptor set domain containing protein 2 transition state and uses thereof
US-2019026440-A1 · Jan 24, 2019 · US
Microfluidic analysis of ligand induced cell expression
US-2019022645-A1 · Jan 24, 2019 · US
Method for profiling protein methylation
US-2018188262-A1 · Jul 5, 2018 · US
Selection of aptamers based on geometry
US-9938641-B2 · Apr 10, 2018 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C40B20/08?
- CPC C40B20/08 is the Cooperative Patent Classification code for “Direct analysis of the library members per se by physical methods, e.g. spectroscopy.”
- How many patents are filed under CPC C40B20/08 (Direct analysis of the library members per se by physical methods, e.g. spectroscopy)?
- Our database includes 28 publications tagged with this CPC code.
- Is patent activity under CPC C40B20/08 growing?
- Publication counts under this code: 2 in 2024 vs 2 in 2025 (latest complete years).